Literature DB >> 23616572

Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.

Miduo Xu1, Rong Hou, Aya Sato-Hayashizaki, Rongyong Man, Chenghua Zhu, Chisato Wakabayashi, Sachiko Hirose, Takahiro Adachi, Takeshi Tsubata.   

Abstract

Although modifier genes are extensively studied in various diseases, little is known about modifier genes that regulate autoimmune diseases. Autoimmune disease caused by the Fas(lpr) mutation depends on the genetic background of mouse strains, suggesting a crucial role of modifier genes. MRL/MpJ-Fas(lpr) (MRL/lpr) and AKR/lpr mice develop severe and mild lupus-like autoimmune disease, respectively, whereas this mutation does not cause disease on C57BL/6 (B6) or C3H background. Both MRL and AKR carry the same haplotype of the Cd72 gene encoding an inhibitory BCR coreceptor (CD72(c)), and CD72(c) contains several amino acid substitutions and a deletion in the extracellular region compared with CD72(a) and CD72(b). To address the role of Cd72(c) locus in the regulation of Fas(lpr)-induced autoimmune disease, we generated B6.CD72(c)/lpr and MRL.CD72(b)/lpr congenic mice. Introduction of the chromosomal interval containing Cd72(c) did not cause disease in B6 mice by itself, but caused development of lupus-like disease in the presence of Fas(lpr) on B6 background, clearly demonstrating that this interval contains the modifier gene that regulates Fas(lpr)-induced autoimmune disease. Conversely, MRL.CD72(b)/lpr congenic mice showed milder disease compared with MRL/lpr mice. We further demonstrated that Cd72(c) is a hypofunctional allele in BCR signal inhibition and that CD72 deficiency induces severe autoimmune disease in the presence of Fas(lpr). These results strongly suggest that the Cd72(c) is a crucial modifier gene that regulates Fas(lpr)-induced autoimmune disease due to its reduced activity of B cell signal regulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23616572     DOI: 10.4049/jimmunol.1203576

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases : English version.

Authors:  T Tsubata
Journal:  Z Rheumatol       Date:  2017-03       Impact factor: 1.372

Review 2.  [CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases. German version].

Authors:  T Tsubata
Journal:  Z Rheumatol       Date:  2016-02       Impact factor: 1.372

3.  A balance between B cell receptor and inhibitory receptor signaling controls plasma cell differentiation by maintaining optimal Ets1 levels.

Authors:  Anne B Satterthwaite; Wei Luo; Jessica Mayeux; Toni Gutierrez; Lisa Russell; Andrew Getahun; Jennifer Müller; Thomas Tedder; Jane Parnes; Robert Rickert; Lars Nitschke; John Cambier; Lee Ann Garrett-Sinha
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

4.  The Role of the Transcription Factor Ets1 in Lupus and Other Autoimmune Diseases.

Authors:  Lee Ann Garrett-Sinha; Alyssa Kearly; Anne B Satterthwaite
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

5.  Activation of TLR7 increases CCND3 expression via the downregulation of miR-15b in B cells of systemic lupus erythematosus.

Authors:  Deshan Ren; Fei Liu; Guanjun Dong; Ming You; Jianjian Ji; Yahong Huang; Yayi Hou; Hongye Fan
Journal:  Cell Mol Immunol       Date:  2015-07-06       Impact factor: 11.530

Review 6.  Role of inhibitory signaling in peripheral B cell tolerance.

Authors:  Andrew Getahun
Journal:  Immunol Rev       Date:  2022-02-06       Impact factor: 12.988

7.  CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm/RNP.

Authors:  Chizuru Akatsu; Kenro Shinagawa; Nobutaka Numoto; Zhihong Liu; Ayse Konuskan Ucar; Mohammad Aslam; Shirly Phoon; Takahiro Adachi; Koji Furukawa; Nobutoshi Ito; Takeshi Tsubata
Journal:  J Exp Med       Date:  2016-10-24       Impact factor: 14.307

Review 8.  Negative regulation of B cell responses and self-tolerance to RNA-related lupus self-antigen.

Authors:  Takeshi Tsubata
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2018       Impact factor: 3.493

9.  Surface Proteomics Reveals CD72 as a Target for In Vitro-Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL.

Authors:  Matthew A Nix; Kamal Mandal; Huimin Geng; Neha Paranjape; Yu-Hsiu T Lin; Jose M Rivera; Makeba Marcoulis; Kristie L White; Jeffrey D Whitman; Sagar P Bapat; Kevin R Parker; Jonathan Ramirez; Anne Deucher; Paul Phojanokong; Veronica Steri; Faranak Fattahi; Byron C Hann; Ansuman T Satpathy; Aashish Manglik; Elliot Stieglitz; Arun P Wiita
Journal:  Cancer Discov       Date:  2021-03-16       Impact factor: 39.397

10.  Intravital imaging of Ca(2+) signals in lymphocytes of Ca(2+) biosensor transgenic mice: indication of autoimmune diseases before the pathological onset.

Authors:  Soichiro Yoshikawa; Takako Usami; Junichi Kikuta; Masaru Ishii; Tetsuo Sasano; Koji Sugiyama; Tetsushi Furukawa; Eiji Nakasho; Hiroshi Takayanagi; Thomas F Tedder; Hajime Karasuyama; Atsushi Miyawaki; Takahiro Adachi
Journal:  Sci Rep       Date:  2016-01-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.